These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

78 related items for PubMed ID: 1687131

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. A twelve month comparison of salmeterol with salbutamol in asthmatic patients. European Study Group.
    Britton MG, Earnshaw JS, Palmer JB.
    Eur Respir J; 1992 Oct; 5(9):1062-7. PubMed ID: 1426215
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A comparison of salmeterol with albuterol in the treatment of mild-to-moderate asthma.
    Pearlman DS, Chervinsky P, LaForce C, Seltzer JM, Southern DL, Kemp JP, Dockhorn RJ, Grossman J, Liddle RF, Yancey SW.
    N Engl J Med; 1992 Nov 12; 327(20):1420-5. PubMed ID: 1357554
    [Abstract] [Full Text] [Related]

  • 5. A comparison of the efficacy of long-acting beta 2-agonists: eformoterol via Turbohaler and salmeterol via pressurized metered dose inhaler or Accuhaler, in mild to moderate asthmatics. Force Research Group.
    Campbell LM, Anderson TJ, Parashchak MR, Burke CM, Watson SA, Turbitt ML.
    Respir Med; 1999 Jul 12; 93(7):236-44. PubMed ID: 10464829
    [Abstract] [Full Text] [Related]

  • 6. Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study.
    Cowie RL, Boulet LP, Keith PK, Scott-Wilson CA, House KW, Dorinsky PM.
    Clin Ther; 2007 Jul 12; 29(7):1390-402. PubMed ID: 17825690
    [Abstract] [Full Text] [Related]

  • 7. Salmeterol xinafoate in children on high dose inhaled steroids.
    Russell G, Williams DA, Weller P, Price JF.
    Ann Allergy Asthma Immunol; 1995 Nov 12; 75(5):423-8. PubMed ID: 7583864
    [Abstract] [Full Text] [Related]

  • 8. A 1-week dose-ranging study of inhaled salmeterol in patients with asthma.
    Bronsky EA, Kemp JP, Orgel HA, Bierman CW, Tinkelman DG, van As A, Liddle RF.
    Chest; 1994 Apr 12; 105(4):1032-7. PubMed ID: 7909285
    [Abstract] [Full Text] [Related]

  • 9. Salmeterol versus theophylline in the treatment of asthma.
    Pollard SJ, Spector SL, Yancey SW, Cox FM, Emmett A.
    Ann Allergy Asthma Immunol; 1997 May 12; 78(5):457-64. PubMed ID: 9164358
    [Abstract] [Full Text] [Related]

  • 10. Initial treatment of symptomatic mild to moderate bronchial asthma with the salmeterol/fluticasone propionate (50/250 microg) combination product (SAS 40023).
    Baumgarten C, Geldszus R, Behre U, Peslis N, Trautmann M, Viani-Initial Study Group.
    Eur J Med Res; 2002 Jan 29; 7(1):1-7. PubMed ID: 11827834
    [Abstract] [Full Text] [Related]

  • 11. Safety of salmeterol in the maintenance treatment of asthma.
    Nathan RA, Seltzer JM, Kemp JP, Chervinsky P, Alexander WJ, Liddle R, Mills R.
    Ann Allergy Asthma Immunol; 1995 Sep 29; 75(3):243-8. PubMed ID: 7552926
    [Abstract] [Full Text] [Related]

  • 12. Tiotropium is noninferior to salmeterol in maintaining improved lung function in B16-Arg/Arg patients with asthma.
    Bateman ED, Kornmann O, Schmidt P, Pivovarova A, Engel M, Fabbri LM.
    J Allergy Clin Immunol; 2011 Aug 29; 128(2):315-22. PubMed ID: 21807250
    [Abstract] [Full Text] [Related]

  • 13. Long-acting beta 2-agonist salmeterol compared with albuterol in maintenance asthma therapy.
    Pearlman DS.
    Ann Allergy Asthma Immunol; 1995 Aug 29; 75(2):180-4. PubMed ID: 7648385
    [Abstract] [Full Text] [Related]

  • 14. Prevention of exercise-induced bronchospasm in pediatric asthma patients: a comparison of salmeterol powder with albuterol.
    Blake K, Pearlman DS, Scott C, Wang Y, Stahl E, Arledge T.
    Ann Allergy Asthma Immunol; 1999 Feb 29; 82(2):205-11. PubMed ID: 10071526
    [Abstract] [Full Text] [Related]

  • 15. [efficacy and safety of salmeterol in long-term therapy in patients with chronic obstructive airway diseases].
    Beeh KM, Wiewrodt R, Salem AE, Buhl R.
    Pneumologie; 2000 Jun 29; 54(6):225-31. PubMed ID: 10934892
    [Abstract] [Full Text] [Related]

  • 16. [Efficacy and safety of salmeterol (50 microgram) and fluticasone (250 microgram) in a single inhaler device (diskus) in patients with mild to moderate asthma].
    Beeh KM, Beier J, Kornmann O, Wiewrodt R, Buhl R, SAS 40011-Studiengruppe.
    Pneumologie; 2002 Feb 29; 56(2):91-7. PubMed ID: 11842346
    [Abstract] [Full Text] [Related]

  • 17. Long-term effects of a long-acting beta 2-adrenoceptor agonist, salmeterol, on airway hyperresponsiveness in patients with mild asthma.
    Cheung D, Timmers MC, Zwinderman AH, Bel EH, Dijkman JH, Sterk PJ.
    N Engl J Med; 1992 Oct 22; 327(17):1198-203. PubMed ID: 1357550
    [Abstract] [Full Text] [Related]

  • 18. Fluticasone propionate and salmeterol administered via Diskus compared with salmeterol or fluticasone propionate alone in patients suboptimally controlled with short-acting beta2-agonists.
    Murray J, Rosenthal R, Somerville L, Blake K, House K, Baitinger L, VanderMeer A, Dorinsky P.
    Ann Allergy Asthma Immunol; 2004 Oct 22; 93(4):351-9. PubMed ID: 15521371
    [Abstract] [Full Text] [Related]

  • 19. Add-on salmeterol compared to double dose fluticasone in pediatric asthma: a double-blind, randomized trial (VIAPAED).
    Gappa M, Zachgo W, von Berg A, Kamin W, Stern-Sträter C, Steinkamp G, VIAPAED Study Group.
    Pediatr Pulmonol; 2009 Nov 22; 44(11):1132-42. PubMed ID: 19824054
    [Abstract] [Full Text] [Related]

  • 20. Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthma.
    Pearlman DS, Stricker W, Weinstein S, Gross G, Chervinsky P, Woodring A, Prillaman B, Shah T.
    Ann Allergy Asthma Immunol; 1999 Mar 22; 82(3):257-65. PubMed ID: 10094216
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.